• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Cubist Pharmaceuticals Inc. (CBST)

    -NasdaqGS
    97.77 0.03(0.03%) Dec 18, 4:00PM EST
    Add to Portfolio
    Prev Close:97.80
    Open:97.94
    Bid:96.05 x 100
    Ask:98.95 x 600
    1y Target Est:96.08
    Beta:1.56
    Earnings Date:Jan 21 - Jan 26 (Est.)
    Day's Range:97.65 - 98.25
    52wk Range:58.50 - 101.82
    Volume:2,193,874
    Avg Vol (3m):1,881,150
    Market Cap:7.46B
    P/E (ttm):113.95
    EPS (ttm):0.86
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Headlines

    » More Headlines for CBST

    Comparison

    Symbol% ChgMkt Cap
    CBSTDown 0.03%7.46B
    PFE201.43B
    TEVA48.42B

    Key Statistics

    Forward P/E (1 yr):54.62
    P/S (ttm):6.41
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :1.13
    Quarterly EPS Est (Dec-14) :0.31
    Mean Recommendation*:2.9
    PEG Ratio (5 yr expected):4.33

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cubist Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of pharmaceutical products for medical needs in the acute care environment in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback